St. Jude PFO Program For Stroke, Migraine Gets Boost With Velocimed Deal

St. Jude Medical will accelerate its patent foramen ovale (PFO) R&D program for stroke treatment by acquiring Velocimed for more than $82.5 mil. under a definitive agreement, the firms said Feb. 15